Evenamide clinical trials
Includes 2 studies of Evenamide hydrochloride.
How each study uses Evenamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Evenamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test Evenamide, phase 3 first.
- Mar 2027Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaPhase 3 · Newron Pharmaceuticals SPA
Studies
Open first, then newest update. How each study uses Evenamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaRecruitingPhase 3Newron Pharmaceuticals SPANCT07184619Written as Evenamide 15 mg bid
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic SchizophreniaCompletedPhase 2Newron Pharmaceuticals SPANCT04461119Written as Evenamide
- An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male SubjectsStatus unknownPhase 1Newron Pharmaceuticals SPANCT03446274Written as Evenamide
- A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.CompletedPhase 1Newron Pharmaceuticals SPANCT01955564Written as NW-3509a
- A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic SchizophreniaCompletedPhase 2Newron Pharmaceuticals SPANCT02624167Written as NW-3509A
Codes
What other systems call Evenamide · ClinicalTrials.gg INT017486
- UNII (FDA) ON5S6N53JSEVENAMIDEConfirmed FDA, Wikidata
- Wikidata Q21098995EvenamideConfirmed FDA, Wikidata
- NCI Thesaurus C174804EvenamideOne source FDA
- DrugBank DB18775One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | ON5S6N53JS | EVENAMIDE | Confirmed FDA, Wikidata |
| Wikidata | Q21098995 | Evenamide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174804 | Evenamide | One source FDA |
| DrugBank | DB18775 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.